Literature DB >> 29574156

Serum extracellular vesicles promote proliferation of H9C2 cardiomyocytes by increasing miR-17-3p.

Zhuyuan Liu1, Zhongrong Zhang2, Jianhua Yao3, Yuan Xie4, Qiying Dai1, Yuhui Zhang5, Lei Zhou6.   

Abstract

Emerging evidence showed that cardiac proliferation played a significant role in the cardiac rehabilitation and repair. Extracellular vesicles (EVs) are known to regulate multiple cell functions, whereas the role of EVs in cardiac proliferation still remains unclear. In this study, we found that serum EVs promoted cell proliferation in rat heart myoblastic H9C2 cells with significantly increased expression level of miR-17-3p. Inhibition of miR-17-3p could decrease H9C2 cells proliferation induced by serum EVs. Additionally, we found that TIMP3 was a target of miR-17-3p in H9C2 cells proliferation and the expression of TIMP3 was downregulated by serum EVs. Meanwhile, inhibition of TIMP3 increased cardiac proliferation. In conclusion, results of our study indicated that serum EVs could promote the proliferation of H9C2 cells via regulating miR-17-3p/TIMP3, which may be a potential therapeutic target for treatment of cardiac injury.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiac; Extracellular vesicles; Proliferation; miR-17-3p

Mesh:

Substances:

Year:  2018        PMID: 29574156     DOI: 10.1016/j.bbrc.2018.03.157

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  Serum Extracellular Vesicles Retard H9C2 Cell Senescence by Suppressing miR-34a Expression.

Authors:  Yang Liu; Zhuyuan Liu; Yuan Xie; Cuimei Zhao; Jiahong Xu
Journal:  J Cardiovasc Transl Res       Date:  2018-11-29       Impact factor: 4.132

Review 2.  Non-canonical features of microRNAs: paradigms emerging from cardiovascular disease.

Authors:  Donato Santovito; Christian Weber
Journal:  Nat Rev Cardiol       Date:  2022-03-18       Impact factor: 49.421

Review 3.  Importance of extracellular vesicles in hypertension.

Authors:  Zhi Z Liu; Pedro A Jose; Jian Yang; Chunyu Zeng
Journal:  Exp Biol Med (Maywood)       Date:  2020-12-06

4.  Circulating microRNA expression profiling and bioinformatics analysis of dysregulated microRNAs of patients with coronary artery disease.

Authors:  Zhixiong Zhong; Jingyuan Hou; Qifeng Zhang; Wei Zhong; Bin Li; Cunren Li; Zhidong Liu; Min Yang; Pingsen Zhao
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

Review 5.  Biology of Tissue Inhibitor of Metalloproteinase 3 (TIMP3), and Its Therapeutic Implications in Cardiovascular Pathology.

Authors:  Dong Fan; Zamaneh Kassiri
Journal:  Front Physiol       Date:  2020-06-16       Impact factor: 4.566

6.  Circ-HIPK3 Strengthens the Effects of Adrenaline in Heart Failure by MiR-17-3p - ADCY6 Axis.

Authors:  Yunfei Deng; Jun Wang; Guojin Xie; Xiaochen Zeng; Hongli Li
Journal:  Int J Biol Sci       Date:  2019-09-07       Impact factor: 6.580

Review 7.  Extracellular Endothelial Cell-Derived Vesicles: Emerging Role in Cardiac and Vascular Remodeling in Heart Failure.

Authors:  Alexander E Berezin; Alexander A Berezin
Journal:  Front Cardiovasc Med       Date:  2020-04-15

Review 8.  Non-coding RNAs to regulate cardiomyocyte proliferation: A new trend in therapeutic cardiac regeneration.

Authors:  Kele Qin; Xiaohui Xie; Weijie Tang; Danni Yang; Jun Peng; Jianjun Guo; Jinfu Yang; Chengming Fan
Journal:  Front Cardiovasc Med       Date:  2022-08-18

Review 9.  Non-coding RNAs in cardiac regeneration: Mechanism of action and therapeutic potential.

Authors:  Yi Wang; Jinghai Chen; Douglas B Cowan; Da-Zhi Wang
Journal:  Semin Cell Dev Biol       Date:  2021-07-17       Impact factor: 7.499

10.  Exosomal miR-17-3p Alleviates Programmed Necrosis in Cardiac Ischemia/Reperfusion Injury by Regulating TIMP3 Expression.

Authors:  Zhuyuan Liu; Didi Zhu; Fuchao Yu; Mingming Yang; Dan Huang; Zhenjun Ji; Wenbin Lu; Genshan Ma
Journal:  Oxid Med Cell Longev       Date:  2022-01-25       Impact factor: 6.543

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.